<--- Back to Details
First PageDocument Content
Financial system / Crédit Agricole / Newedge Group / Dodd–Frank Wall Street Reform and Consumer Protection Act / Derivative / Commodity Futures Trading Commission / Futures contract / Clearing house / Over-the-counter / Financial economics / Finance / Systemic risk
Date: 2013-12-11 16:43:37
Financial system
Crédit Agricole
Newedge Group
Dodd–Frank Wall Street Reform and Consumer Protection Act
Derivative
Commodity Futures Trading Commission
Futures contract
Clearing house
Over-the-counter
Financial economics
Finance
Systemic risk

OVERVIEW AND COMPLEXITY OF CHANGING REGULATORY REQUIREMENTS Eileen T. Flaherty Global Head of Compliance and Financial Crime Prevention

Add to Reading List

Source URL: www.chicagofed.org

Download Document from Source Website

File Size: 93,51 KB

Share Document on Facebook

Similar Documents

Incentives to centrally clear over-the-counter (OTC) derivatives: A post-implementation evaluation of the effects of the G20 financial regulatory reforms

Incentives to centrally clear over-the-counter (OTC) derivatives: A post-implementation evaluation of the effects of the G20 financial regulatory reforms

DocID: 1xTGW - View Document

[723]  VOL. CCCXXIX OVER THE COUNTER SALES $2·75 INCLUDING G.S.T.

[723] VOL. CCCXXIX OVER THE COUNTER SALES $2·75 INCLUDING G.S.T.

DocID: 1vs3W - View Document

What do we mean by…? What do you mean by

What do we mean by…? What do you mean by "drug"? We define a drug as a substance people take to change the way they feel, think or behave. This term encompasses all prescribed and over-the-counter medicines, all legal

DocID: 1viqm - View Document

FDA revises restriction on over-the-counter access to Plan B emergency contraception to women 17 and over

FDA revises restriction on over-the-counter access to Plan B emergency contraception to women 17 and over

DocID: 1vekW - View Document

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-The Counter Monograph: Study Elements and Considerations Guidance for Industry

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-The Counter Monograph: Study Elements and Considerations Guidance for Industry

DocID: 1v9zy - View Document